Accreditation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine designates this Internet Enduring Material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ABPLM Designation Statement: This Internet Enduring Material has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for a total of 1.5 management hours toward certification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. The CMD program is administered by the ABPLM. Each physician should claim only those hours of credit actually spent on the activity.
Session Description: This program will outline the requirements and describe the integration of Medication Therapy Management (MTM) services into care planning of long-term care residents. Through collaboration, pharmacists, nurses, and physicians can improve care for residents with complex needs receiving high-risk medications, such as antipsychotics, anticoagulants, and antithrombotics. Most MTM interventions are focused on conditions such as congestive heart failure, dementia, depression, anxiety, and COPD. Residents with these complex care needs as well as their families can benefit from Comprehensive Medication Reviews and targeted follow-up interventions. Integrated collaborative practice approaches involving the resident, their nurse, pharmacist and medical director are a focus of MTM programs in long-term care.
Define the roles of the Medical Director and Nurse Practitioner in collaborating with pharmacists to deliver Comprehensive Medication Reviews and Targeted Medication Therapy Management for residents of long term care facilities
Articulate the obstacles and tactics to overcome obstacles present in conducting MTM in the LTC environment
Outline components of delivering a successful approach to MTM in LTC
Apply the principles of MTM to a LTC resident case scenario
Speaker(s): Barbara Zarowitz, PharmD, CGP Eric Tangalos, MD, CMD Barbara Resnick, PhD, CRNP Nicole Brandt, PharmD, CGP
Disclosure(s): Dr. Zarowitz - Employee and Stockholder: Omnicare, Inc.
Reference(s): 1. Tudor CG. CMS Memorandum: "CY 2013 Medication Therapy Management Program Guidance and Submission Instructions". Issued 10 April, 2012. Accessed 2/24/2014 at http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/MTM.html. 2. Medicare Part D Medication Therapy Management Program Standardized Format. Accessed 2/24/2014 at http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/MTM.html. 3. Perlroth D, Olinger L, Marrufo G et al. Medication Therapy Management in Chronically Ill Populations: Final Report. August 2013. Accessed 2/28/2014 at http://innovation.cms.gov/Files/reports/MTM_Final_Report.pdf. 4. Medicare Program: Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs". (proposed rule). United States Federal Register /Vol. 79, No. 7 /Friday January 10, 2014 /Proposed Rules. Accessed 3/17/2014 at http://www.gpo.gov/fdsys/pkg/FR-2014-01-10/pdf/2013-31497.pdf. 5. Gruber J. Medication Therapy Management: A Challenge For Pharmacists. Consult Pharm 2012; 27: 782-96. 6. McSpadden C. A New Ballgame: Comprehensive Medication Review. Consult Pharm 2014; 29 (2): 76-83.